Health & Biotech
Hygrovest Limited (“Hygrovest”) (ASX: HGV) is an Australian listed, specialist investment company that has traded on the ASX since 2015. Investors in Hygrovest gain exposure to a portfolio which concentrates on producing capital growth for shareholders over the medium to long term from investments in listed and unlisted equities and other financial assets.
Investments are managed by Parallax Ventures Inc., a specialist management company in Canada, under a longterm strategic partnership.
In December 2021 HGV changed to change its name to “Hygrovest Limited” from MMJ Group Holdings Limited. The ASX code has also changed from MMJ to HGV.
Since 2015, Hygrovest has created a significant number of investment opportunities from its connections in Canada and Australia in the private investment sector and realised exits to the benefit of Hygrovest and its shareholders.
RELATED STOCKHEAD STORIES
Health & Biotech
Biotech big guns are buying up the minnows
Health & Biotech
Cannabis: MMJ drops $2.2m on North American Harvest One
Health & Biotech
Weed Week: Wait till cannabis is legalised federally in the US – big pharma are already dreading it
Health & Biotech
Cannabis: THC just got those long-awaited narcotics licenses
Health & Biotech
Weed Week: G-men getting on the hype train
News
Weed Week: Oz gets serious with medical marijuana, new clinics rolling out soon
Health & Biotech
Expert view: Here are 3 things we learned about where the cannabis industry is headed
Health & Biotech